by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; Susan L. McElroy, MD; Jana Radewonuk, MSc; Barry K. Herman, MD, MMM; and James Hudson, MD, ScD Dr. Sheehan is
John M. Morton, MD, MPH, FACS, FASMBS, Clinical Editor, Metabolic & Bariatric Care Times; Chief of the Section of Bariatric and Minimally Invasive Surgery, Stanford University, Stanford, California, and Past
Christopher Still, DO, FACN, FACP, Co-Clinical Editor, Metabolic & Bariatric Care Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute, Geisinger
This activity expired September 1, 2020. Course Overview: Type 2 diabetes mellitus (T2DM) is a major public health problem that is significantly linked to another worldwide epidemic—obesity. Over the decades,
An Interview with: Wendy Scinta MD, MS President of the Obesity Medicine Association; Medical Director of Medical Weight Loss of New York, Fayetteville, New York; Founder of the BOUNCE Pediatric
by Dominick Gadaleta, MD, FACS, FASMBS; and Anthony T. Petrick, MD, FACS, FASMBS This column is dedicated to highlighting a broad range of quality issues in bariatric surgery. Column Editors
by Claudia Randall Claudia Randall is the executive director of the Obesity Medicine Association. FUNDING: No funding was provided for this article. DISCLOSURES: The author is the executive director of
by Rami E. Lutfi, MD, FACS, FASMBS Clinical Associate Professor of Surgery, University of Illinois at Chicago; Chairman of Surgery, Mercy Hospital and Medical Center; Director, Presence Chicago Institute of